mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |